175.30

1.93% -3.51

Iqvia Holdings Inc (IQV)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$178.81

Aprire:

$174.81

Volume 24 ore:

685.53K

Relative Volume:

0.36

Capitalizzazione di mercato:

$29.73B

Reddito:

$16.30B

Utile/perdita netta:

$1.36B

Rapporto P/E:

22.31

EPS:

7.8573

Flusso di cassa netto:

$2.05B

1 W Prestazione:

+8.04%

1M Prestazione:

-24.16%

6M Prestazione:

-4.56%

1 anno Prestazione:

-7.12%

Intervallo 1D:

$172.45

$177.21

Intervallo di 1 settimana:

$160.00

$179.25

Portata 52W:

$134.65

$247.04

Iqvia Holdings Inc Stock (IQV) Company Profile

Nome

Iqvia Holdings Inc

Settore

Healthcare (1114)

Industria

Diagnostics & Research (53)

Telefono

919-998-2000

Indirizzo

2400 ELLIS ROAD, DURHAM, NC

Dipendente

93,000

Cinguettio

@IQVIA_global

Prossima data di guadagno

2025-07-22

Ultimi documenti SEC

IQV's Discussions on Twitter

Compare IQV vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IQV Iqvia Holdings Inc	175.22	30.34B	16.30B	1.36B	2.05B	7.8573
TMO Thermo Fisher Scientific Inc	506.13	195.79B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	205.97	148.95B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	635.10	52.44B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	118.14	34.33B	6.95B	1.30B	1.15B	4.5696
WAT Waters Corp	311.38	31.33B	3.17B	642.63M	516.49M	10.77

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-02	Ripresa	Morgan Stanley	Overweight
2025-11-13	Iniziato	BMO Capital Markets	Outperform
2025-11-03	Downgrade	TD Cowen	Buy → Hold
2025-10-29	Aggiornamento	Robert W. Baird	Neutral → Outperform
2025-10-09	Aggiornamento	HSBC Securities	Hold → Buy
2025-09-09	Aggiornamento	Jefferies	Hold → Buy
2025-04-25	Downgrade	HSBC Securities	Buy → Hold
2025-04-10	Downgrade	Barclays	Overweight → Equal Weight
2025-02-03	Downgrade	BTIG Research	Buy → Neutral
2024-12-20	Iniziato	Stephens	Overweight
2024-10-14	Iniziato	Redburn Atlantic	Buy
2024-09-04	Iniziato	RBC Capital Mkts	Outperform
2024-07-24	Downgrade	Jefferies	Buy → Hold
2024-06-06	Iniziato	Goldman	Buy
2024-02-26	Iniziato	Leerink Partners	Outperform
2024-02-15	Downgrade	Guggenheim	Buy → Neutral
2024-02-13	Iniziato	BTIG Research	Buy
2023-11-02	Downgrade	Robert W. Baird	Outperform → Neutral
2023-09-06	Iniziato	HSBC Securities	Buy
2023-03-17	Iniziato	Truist	Buy
2022-12-06	Iniziato	Cowen	Outperform
2022-11-17	Downgrade	Citigroup	Buy → Neutral
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-07-15	Iniziato	SVB Leerink	Outperform
2022-05-24	Iniziato	Guggenheim	Buy
2022-04-29	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-04-16	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-03-08	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-03	Iniziato	Barclays	Overweight
2020-07-07	Iniziato	Stephens	Equal-Weight
2020-03-02	Iniziato	Deutsche Bank	Buy
2020-01-08	Iniziato	Wells Fargo	Overweight
2020-01-07	Iniziato	Citigroup	Buy
2019-12-13	Aggiornamento	CFRA	Sell → Hold
2019-11-14	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2019-06-21	Aggiornamento	Mizuho	Neutral → Buy
2019-05-28	Iniziato	SVB Leerink	Outperform
2019-01-18	Aggiornamento	Jefferies	Hold → Buy
2018-10-09	Iniziato	UBS	Buy
2018-10-02	Reiterato	Robert W. Baird	Outperform
2018-07-25	Aggiornamento	BofA/Merrill	Neutral → Buy
2018-07-25	Reiterato	Stifel	Buy
2018-07-03	Aggiornamento	Raymond James	Outperform → Strong Buy
2018-04-13	Aggiornamento	Goldman	Neutral → Buy
2018-03-07	Aggiornamento	SunTrust	Hold → Buy
2018-01-19	Iniziato	Evercore ISI	Outperform

Mostra tutto

Iqvia Holdings Inc Borsa (IQV) Ultime notizie

Mar 01, 2026

IQVIA Acquires Charles River Assets for $145 Million: Here’s the Street’s Scenario for 70% Upside - TIKR.com

Mar 01, 2026

TD Asset Management Inc Grows Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat

Mar 01, 2026

Handelsbanken Fonder AB Sells 52,327 Shares of IQVIA Holdings Inc. $IQV - MarketBeat

Mar 01, 2026

Feb 28, 2026

Keystone Investors PTE Ltd. Has $27.78 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 28, 2026

Erste Asset Management GmbH Trims Stock Position in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 28, 2026

Mitsubishi UFJ Asset Management Co. Ltd. Buys 17,121 Shares of IQVIA Holdings Inc. $IQV - MarketBeat

Feb 28, 2026

IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder (NYSE:IQV) - Seeking Alpha

Feb 28, 2026

Feb 27, 2026

IQVIA Releases its 2025 Sustainability Report - Business Wire

Feb 27, 2026

Primecap Management Co. CA Has $89.11 Million Stock Holdings in IQVIA Holdings Inc. $IQV - MarketBeat

Feb 27, 2026

Charles River Laboratories to divest a number of assets to IQVIA and GI Partners - Business Weekly

Feb 27, 2026

Is IQVIA Holdings Inc. (IQV) a Buy Post Earnings? - Finviz

Feb 27, 2026

Feb 26, 2026

IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity - Insider Monkey

Feb 26, 2026

IQVIA to acquire Charles River drug discovery assets - Yahoo Finance

Feb 26, 2026

3 Reasons to Sell IQV and 1 Stock to Buy Instead - Finviz

Feb 26, 2026

IQVIA Acquisition Expands Drug Discovery Role And Highlights Valuation Gap - Yahoo Finance

Feb 26, 2026

Feb 25, 2026

IQVIA to acquire drug discovery assets from Charles River Labs By Investing.com - Investing.com Australia

Feb 25, 2026

IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Feb 25, 2026

Activist investor prompts sale of Charles River CDMO business, U.S. and European sites - The Business Journals

Feb 25, 2026

IQVIA Holdings Inc. (NYSE : IQV) entered into a definitive agreement to acquire European Discovery Services Assets from Charles River Laboratories International, Inc. (NYSE - marketscreener.com

Feb 25, 2026

IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities - 01net

Feb 25, 2026

Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans - Benzinga

Feb 25, 2026

Did AI‑Driven Obesity Research Wins and Strong 2025 Results Just Shift IQVIA's (IQV) Investment Narrative? - simplywall.st

Feb 25, 2026

IQVIA to acquire drug discovery assets from Charles River Labs - Investing.com

Feb 25, 2026

Charles River raises annual profit view as it sells underperforming assets - marketscreener.com

Feb 25, 2026

Iqvia signs agreement to acquire drug discovery assets from Charles River Laboratories, expanding end-to-end drug discovery capabilities - marketscreener.com

Feb 25, 2026

Charles River Laboratories Provides Update on Planned Divestitures - Business Wire

Feb 25, 2026

Feb 24, 2026

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Feb 24, 2026